NCT06750094 · Interventional trial
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Overall registry status Recruiting
Phase 3
Conditions Colorectal Neoplasms
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory